Structure Therapeutics Inc.
GPCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $108,814 | $70,103 | $36,193 | $29,111 |
| G&A Expenses | $49,414 | $32,672 | $16,368 | $8,585 |
| SG&A Expenses | $49,414 | $32,672 | $16,368 | $8,585 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $158,228 | $102,775 | $52,561 | $37,696 |
| Operating Income | -$158,228 | -$102,775 | -$52,561 | -$37,696 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $36,012 | $13,391 | $1,257 | -$122 |
| Pre-Tax Income | -$122,216 | -$89,384 | -$51,304 | -$37,818 |
| Tax Expense | $310 | $236 | $17 | $231 |
| Net Income | -$122,526 | -$89,620 | -$51,321 | -$40,008 |
| % Margin | – | – | – | – |
| EPS | -2.34 | -2.43 | -1.44 | -1.2 |
| % Growth | 3.7% | -68.8% | -20% | – |
| EPS Diluted | -2.34 | -2.43 | -1.44 | -1.2 |
| Weighted Avg Shares Out | 52,641 | 36,733 | 36,588 | 36,588 |
| Weighted Avg Shares Out Dil | 52,641 | 36,733 | 36,588 | 36,588 |
| Supplemental Information | – | – | – | – |
| Interest Income | $36,030 | $13,379 | $1,256 | $0 |
| Interest Expense | $0 | $13,391 | $0 | $122 |
| Depreciation & Amortization | $992 | $295 | $277 | $72 |
| EBITDA | -$157,236 | -$102,480 | -$52,284 | -$37,624 |
| % Margin | – | – | – | – |